{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:26:14Z","timestamp":1790364374029,"version":"4.1.0"},"reference-count":247,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:00:00Z","timestamp":1606262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011019","name":"Nemzeti Kutat\u00e1si Fejleszt\u00e9si \u00e9s Innov\u00e1ci\u00f3s Hivatal","doi-asserted-by":"publisher","award":["PD-128370"],"award-info":[{"award-number":["PD-128370"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hungarian National Research, Development and Innovation Office","award":["GINOP-2.3.2-15-2016-00044"],"award-info":[{"award-number":["GINOP-2.3.2-15-2016-00044"]}]},{"name":"Ministry for Innovation and Technology in Hungary","award":["ED_18-1-2019-0028"],"award-info":[{"award-number":["ED_18-1-2019-0028"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Muscular dystrophies are a group of more than 160 different human neuromuscular disorders characterized by a progressive deterioration of muscle mass and strength. The causes, symptoms, age of onset, severity, and progression vary depending on the exact time point of diagnosis and the entity. Congenital myopathies are rare muscle diseases mostly present at birth that result from genetic defects. There are no known cures for congenital myopathies; however, recent advances in gene therapy are promising tools in providing treatment. This review gives an overview of the mouse models used to investigate the most common muscular dystrophies and congenital myopathies with emphasis on their potentials and limitations in respect to human applications.<\/jats:p>","DOI":"10.3390\/ijms21238935","type":"journal-article","created":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T08:59:15Z","timestamp":1606294755000},"page":"8935","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["From Mice to Humans: An Overview of the Potentials and Limitations of Current Transgenic Mouse Models of Major Muscular Dystrophies and Congenital Myopathies"],"prefix":"10.3390","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5946-6986","authenticated-orcid":false,"given":"M\u00f3nika","family":"Sztretye","sequence":"first","affiliation":[{"name":"Department of Physiology, Faculty of Medicine, University of Debrecen, H-4002 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"Szab\u00f3","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Medicine, University of Debrecen, H-4002 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00f3ra","family":"Dobrosi","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Medicine, University of Debrecen, H-4002 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e1nos","family":"Fodor","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Medicine, University of Debrecen, H-4002 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2621-2282","authenticated-orcid":false,"given":"P\u00e9ter","family":"Szentesi","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Medicine, University of Debrecen, H-4002 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e1nos","family":"Alm\u00e1ssy","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Medicine, University of Debrecen, H-4002 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna \u00c9.","family":"Magyar","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Medicine, University of Debrecen, H-4002 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3110-0296","authenticated-orcid":false,"given":"Beatrix","family":"Dienes","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Medicine, University of Debrecen, H-4002 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2446-1456","authenticated-orcid":false,"given":"L\u00e1szl\u00f3","family":"Csernoch","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Medicine, University of Debrecen, H-4002 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: The protein product of the duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/ng0493-283","article-title":"The structural and functional diversity of dystrophin","volume":"3","author":"Ahn","year":"1993","journal-title":"Nat. Genet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00439-004-1189-4","article-title":"Duchenne muscular dystrophy","volume":"115","author":"Emery","year":"2004","journal-title":"Hum. Genet."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-017-0631-3","article-title":"The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: An evidence review","volume":"12","author":"Ryder","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ejhg.2012.301","article-title":"Newborn bloodspot screening for Duchenne Muscular Dystrophy: 21 years experience in Wales (UK)","volume":"21","author":"Moat","year":"2013","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1542\/peds.2014-2044","article-title":"Prevalence of Duchenne and Becker Muscular Dystrophies in the United States","volume":"135","author":"Romitti","year":"2015","journal-title":"Pediatrics"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1196\/annals.1363.013","article-title":"The role of Ca2+ in muscle cell damage","volume":"1066","author":"Gissel","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_8","first-page":"184","article-title":"The role of fibrosis in Duchenne muscular dystrophy","volume":"31","author":"Klingler","year":"2012","journal-title":"Acta Myol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1146\/annurev.physiol.010908.163216","article-title":"Mechanisms of muscle degeneration, regeneration, and repair in the muscular dystrophies","volume":"71","author":"Wallace","year":"2009","journal-title":"Annu. Rev. Physiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2008.03.008","article-title":"Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy","volume":"31","author":"Grounds","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/352536a0","article-title":"The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy","volume":"352","author":"Stedman","year":"1991","journal-title":"Nature"},{"key":"ref_12","first-page":"54","article-title":"Exploring the molecular basis for variability among patients with Becker muscular dystrophy: Dystrophin gene and protein studies","volume":"49","author":"Beggs","year":"1991","journal-title":"Am. J. Hum. Genet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/humu.20422","article-title":"Protein- and mRNA-Based Phenotype\u2013Genotype Correlations in DMD\/BMD With Point Mutations and Molecular Basis for BMD With Nonsense and Frameshift Mutations in the DMD Gene","volume":"28","author":"Deburgrave","year":"2007","journal-title":"Hum Mutat."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1242\/dmm.018424","article-title":"Animal models of Duchenne muscular dystrophy: From basic mechanisms to gene therapy","volume":"8","author":"McGreevy","year":"2015","journal-title":"DMM Dis. Model. Mech."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1073\/pnas.81.4.1189","article-title":"X chromosome-linked muscular dystrophy (mdx) in the mouse","volume":"81","author":"Bulfield","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10517-009-0564-5","article-title":"A new Genetic variant of MDX mice: Study of the phenotype","volume":"147","author":"Krivov","year":"2009","journal-title":"Bull. Exp. Biol. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pgen.1002042","article-title":"DNA damage, somatic aneuploidy, and malignant sarcoma susceptibility in muscular dystrophies","volume":"7","author":"Schmidt","year":"2011","journal-title":"PLoS Genet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.2353\/ajpath.2010.090887","article-title":"Genetic background affects properties of satellite cells and mdx phenotypes","volume":"176","author":"Fukada","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_19","first-page":"1","article-title":"The FVB Background Does Not Dramatically Alter the Dystrophic Phenotype of Mdx Mice","volume":"7","author":"Wasala","year":"2015","journal-title":"PloS Curr."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1073\/pnas.86.4.1292","article-title":"Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice","volume":"86","author":"Chapman","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1113\/expphysiol.2008.045864","article-title":"Generation of N-ethyl-N-nitrosourea-induced mouse mutants with deviations in plasma enzyme activities as novel organ-specific disease models","volume":"94","author":"Aigner","year":"2009","journal-title":"Exp. Physiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1006\/bbrc.1997.7328","article-title":"Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in duchenne muscular dystrophy","volume":"238","author":"Araki","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/(SICI)1097-0177(199806)212:2<229::AID-AJA7>3.0.CO;2-J","article-title":"Dmd(mdx-\u03b2geo): A new allele for the mouse dystrophin gene","volume":"212","author":"Wertz","year":"1998","journal-title":"Dev. Dyn."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bbrc.2004.12.191","article-title":"A new model mouse for Duchenne muscular dystrophy produced by 2.4 Mb deletion of dystrophin gene using Cre-loxP recombination system","volume":"328","author":"Kudoh","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/hmg\/8.1.1","article-title":"Targeted inactivation of Dp71, the major non-muscle product of the DMD gene: Differential activity of the Dp71 promoter during development","volume":"8","author":"Sarig","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"ref_26","first-page":"1480","article-title":"Lack of dystrophin protein Dp71 results in progressive cataract formation due to loss of fiber cell organization","volume":"20","author":"Fort","year":"2014","journal-title":"Mol. Vis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/nm.3628","article-title":"Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice","volume":"20","author":"Wein","year":"2014","journal-title":"Nat. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/stem.1402","article-title":"A new immuno-, dystrophin-deficient model, the NSG-mdx4Cv mouse, provides evidence for functional improvement following allogeneic satellite cell transplantation","volume":"31","author":"Arpke","year":"2013","journal-title":"Stem Cells"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1038\/mt.2012.189","article-title":"Proinflammatory macrophages enhance the regenerative capacity of human myoblasts by modifying their kinetics of proliferation and differentiation","volume":"20","author":"Bencze","year":"2012","journal-title":"Mol. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1038\/mt.2013.186","article-title":"The Rag2 - Il2rb - Dmd - Mouse: A novel dystrophic and immunodeficient model to assess innovating therapeutic strategies for muscular dystrophies","volume":"21","author":"Vallese","year":"2013","journal-title":"Mol. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/path.2213","article-title":"T and B lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid\/mdx mouse","volume":"213","author":"Farini","year":"2007","journal-title":"J. Pathol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0027500","article-title":"Myogenic reprogramming of bone marrow derived cells in a W41Dmdmdx deficient mouse model","volume":"6","author":"Walsh","year":"2011","journal-title":"PLoS ONE"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1242\/jcs.02952","article-title":"Severe muscular dystrophy in mice that lack dystrophin and \u03b17 integrin","volume":"119","author":"Rooney","year":"2006","journal-title":"J. Cell Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/hmg\/ddl018","article-title":"Absence of \u03b17 integrin in dystrophin-deficient mice causes a myopathy similar to Duchenne muscular dystrophy","volume":"15","author":"Guo","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0092-8674(00)80533-4","article-title":"Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: A model for Duchenne muscular dystrophy","volume":"90","author":"Grady","year":"1997","journal-title":"Cell"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.nmd.2010.02.016","article-title":"Expanding the clinical, pathological and MRI phenotype of DNM2-related centronuclear myopathy","volume":"20","author":"Susman","year":"2010","journal-title":"Neuromuscul. Disord."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/hmg\/ddp015","article-title":"Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice","volume":"18","author":"Li","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pgen.1004431","article-title":"Muscle Structure Influences Utrophin Expression in mdx Mice","volume":"10","author":"Banks","year":"2014","journal-title":"PLoS Genet."},{"key":"ref_39","first-page":"1167","article-title":"Dmdmdx\/Largemyd: A new mouse model of neuromuscular diseases useful for studying physiopathological mechanisms and testing therapies","volume":"6","author":"Martins","year":"2013","journal-title":"DMM Dis. Model. Mech."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.mod.2014.12.001","article-title":"Roles of ADAM8 in elimination of injured muscle fibers prior to skeletal muscle regeneration","volume":"135","author":"Nishimura","year":"2015","journal-title":"Mech. Dev."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2044-5040-1-35","article-title":"Dystrophin deficiency exacerbates skeletal muscle pathology in dysferlin-null mice","volume":"1","author":"Han","year":"2011","journal-title":"Skelet. Muscle"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.cancergen.2012.03.005","article-title":"Dystrophin and dysferlin double mutant mice: A novel model for rhabdomyosarcoma","volume":"205","author":"Hosur","year":"2012","journal-title":"Cancer Genet."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1093\/hmg\/ddu113","article-title":"Dystrophic mdx mice develop severe cardiac and respiratory dysfunction following genetic ablation of the anti-inflammatory cytokine IL-10","volume":"23","author":"Chiyo","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.cell.2010.11.039","article-title":"Short telemeres and stem cell exhaustion model in mdx mice","volume":"143","author":"Sacco","year":"2010","journal-title":"Cell"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1101\/gad.10.10.1173","article-title":"MyoD is required for myogenic stem cell function in adult skeletal muscle","volume":"10","author":"Megeney","year":"1996","journal-title":"Genes Dev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(00)80532-2","article-title":"Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy","volume":"90","author":"Deconinck","year":"1997","journal-title":"Cell"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1083\/jcb.201105013","article-title":"PAI-1-regulated miR-21 defines a novel age-associated fibrogenic pathway in muscular dystrophy","volume":"196","author":"Ardite","year":"2012","journal-title":"J. Cell Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/364725a0","article-title":"Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity","volume":"364","author":"Cox","year":"1993","journal-title":"Nature"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/hmg\/4.8.1251","article-title":"Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice","volume":"4","author":"Phelps","year":"1995","journal-title":"Hum. Mol. Genet."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/hmg\/2.6.717","article-title":"Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo","volume":"2","author":"Dunckley","year":"1993","journal-title":"Hum. Mol. Genet."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ng1294-333","article-title":"Dp71 can restore the dystrophin-associated glycoprotein complex in muscle but fails to prevent dystrophy","volume":"8","author":"Cox","year":"1994","journal-title":"Nat. Genet."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/ng1294-340","article-title":"Exogenous Dp71 restores the levels of dystrophin associated proteins but does not alleviate muscle damage in mdx mice","volume":"8","author":"Greenberg","year":"1994","journal-title":"Nat. Genet."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"4978","DOI":"10.1093\/hmg\/ddr433","article-title":"Expression of the dystrophin isoform Dp116 preserves functional muscle mass and extends lifespan without preventing dystrophy in severely dystrophic mice","volume":"20","author":"Judge","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1242\/jcs.02857","article-title":"Dissecting the signalling and mechanical functions of the dystrophin-glycoprotein complex","volume":"119","author":"Judge","year":"2006","journal-title":"J. Cell Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/hmg\/11.9.1095","article-title":"Expression of Dp260 in muscle tethers the actin cytoskeleton to the dystrophin-glycoprotein complex and partially prevents dystrophy","volume":"11","author":"Warner","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nmd.2005.12.007","article-title":"Improvement in survival and muscle function in an mdx\/utrn-\/- double mutant mouse using a human retinal dystrophin transgene","volume":"16","author":"Gaedigk","year":"2006","journal-title":"Neuromuscul. Disord."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1097-2765(02)00572-5","article-title":"Loss of the Muscle-Specific Chloride Channel in Type 1 Myotonic Dystrophy Due to Misregulated Alternative Splicing several lines of evidence indicate that a gain of function for RNA CUG)n","volume":"10","author":"Savkur","year":"2002","journal-title":"Mol. Cell"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1152\/japplphysiol.00866.2012","article-title":"Truncated dystrophins reduce muscle stiffness in the extensor digitorum longus muscle of mdx mice","volume":"114","author":"Hakim","year":"2013","journal-title":"J. Appl. Physiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/gt.2008.104","article-title":"Construction and analysis of compact muscle-specific promoters for AAV vectors","volume":"15","author":"Wang","year":"2008","journal-title":"Gene Ther."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/sj.gt.3302242","article-title":"Long-term expression of full-length human dystrophin in transgenic mdx mice expressing internally deleted human dystrophins","volume":"11","author":"Ferrer","year":"2004","journal-title":"Gene Ther."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/4033","article-title":"Expression of full-length utrophin prevents muscular dystrophy in mdx mice","volume":"4","author":"Tinsley","year":"1998","journal-title":"Nat. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1242\/jcs.064808","article-title":"Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin","volume":"123","author":"Li","year":"2010","journal-title":"J. Cell Sci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.ajpath.2010.12.030","article-title":"Transgenic expression of laminin \u03b11 chain does not prevent muscle disease in the mdx mouse model for Duchenne muscular dystrophy","volume":"178","author":"Gawlik","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/BF00121296","article-title":"Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch","volume":"14","author":"Moens","year":"1993","journal-title":"J. Muscle Res. Cell Motil."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.2173137","article-title":"Increased activity of calcium leak channels in myotubes of Duchenne human and mdx mouse origin","volume":"250","author":"Fong","year":"1990","journal-title":"Science"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF00232023","article-title":"Proteolysis results in altered leak channel kinetics and elevated free calcium in mdx muscle","volume":"133","author":"Turner","year":"1993","journal-title":"J. Membr. Biol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0960-8966(01)00279-6","article-title":"Normal calcium homeostasis in dystrophin-expressing facioscapulohumeral muscular dystrophy myotubes","volume":"12","author":"Vandebrouck","year":"2002","journal-title":"Neuromuscul. Disord."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1073\/pnas.071048198","article-title":"Excitation - Contraction uncoupling by a human central core disease mutation in the ryanodine receptor","volume":"98","author":"Avila","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/CIRCRESAHA.107.162982","article-title":"Prevention of dystrophin-deficient cardiomyopathy in twenty-one-month-old carrier mice by mosaic dystrophin expression or complementary dystrophin\/utrophin expression","volume":"102","author":"Bostick","year":"2008","journal-title":"Circ. Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/mt.2008.264","article-title":"Cardiac expression of a mini-dystrophin that normalizes skeletal muscle force only partially restores heart function in aged Mdx mice","volume":"17","author":"Bostick","year":"2009","journal-title":"Mol. Ther."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1152\/japplphysiol.01425.2010","article-title":"The passive mechanical properties of the extensor digitorum longus muscle are compromised in 2-to 20-mo-old mdx mice","volume":"110","author":"Hakim","year":"2011","journal-title":"J. Appl. Physiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/ar.1092420109","article-title":"Phenotype of dystrophinopathy in old MDX mice","volume":"242","author":"Lefaucheur","year":"1995","journal-title":"Anat. Rec."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0022-510X(94)00276-T","article-title":"Mdx Mice Show Progressive Weakness and Muscle Deterioration With Age","volume":"129","author":"Pastoret","year":"1995","journal-title":"J. Neurol. Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/hmg\/5.8.1149","article-title":"Differential expression of dystrophin isoforms in strains of mdx mice with different mutations","volume":"5","author":"Im","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1073\/pnas.96.1.220","article-title":"Severe cardiomyopathy in mice lacking dystrophin and MyoD","volume":"96","author":"Megeney","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/ncb2790","article-title":"Role of Telomere Dysfunction in Cardiac Failure in Duchenne Muscular Dystrophy","volume":"15","author":"Mourkioti","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1152\/ajpcell.00056.2011","article-title":"Stretch-activated calcium channel protein TRPC1 is correlated with the different degrees of the dystrophic phenotype in mdx mice","volume":"301","author":"Matsumura","year":"2011","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1161\/CIRCULATIONAHA.111.031716","article-title":"Early Treatment with Lisinopril and Spironolactone Preserves Cardiac and Skeletal Muscle in Duchenne Muscular Dystrophy Mice","volume":"124","author":"Chimanji","year":"2011","journal-title":"Circulation"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.nmd.2011.10.011","article-title":"Comparison of skeletal muscle pathology and motor function of dystrophin and utrophin deficient mouse strains","volume":"22","author":"Kumar","year":"2012","journal-title":"Neuromuscul. Disord."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/ilar\/ilv015","article-title":"Porcine models of muscular dystrophy","volume":"56","author":"Selsby","year":"2015","journal-title":"ILAR J."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.nmd.2018.05.007","article-title":"229th ENMC international workshop: Limb girdle muscular dystrophies\u2013Nomenclature and reformed classification Naarden, The Netherlands, 17\u201319 March 2017","volume":"28","author":"Straub","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.nmd.2013.02.004","article-title":"Muscular dystrophy in dysferlin-deficient mouse models","volume":"23","author":"Hornsey","year":"2013","journal-title":"Neuromuscul. Disord."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"van Putten, M., Lloyd, E.M., de Greef, J.C., Raz, V., Willmann, R., and Grounds, M.D. (2020). Mouse models for muscular dystrophies: An overview. Dis. Model. Mech., 13.","DOI":"10.1242\/dmm.043562"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1126\/science.8469976","article-title":"Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy","volume":"260","author":"Fu","year":"1993","journal-title":"Science"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/ng0796-316","article-title":"Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice","volume":"13","author":"Jansen","year":"1996","journal-title":"Nat. Genet."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/hmg\/8.8.1491","article-title":"Myotonic dystrophy is associated with a reduced level of RNA from the DMWD allele adjacent to the expanded repeat","volume":"8","author":"Alwazzan","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s100480000103","article-title":"Does (CUG)n repeat in DMPK mRNA \u201cpaint\u201d chromosome 19 to suppress distant genes to create the diverse phenotype of myotonic dystrophy?: A new hypothesis of long-range cis autosomal inactivation","volume":"3","author":"Junghans","year":"2001","journal-title":"Neurogenetics"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/75490","article-title":"Mice deficient in Six5 develop cataracts: Implications for myotonic dystrophy","volume":"25","author":"Klesert","year":"2000","journal-title":"Nat. Genet."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/75500","article-title":"Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts","volume":"25","author":"Sarkar","year":"2000","journal-title":"Nat. Genet."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1126\/science.289.5485.1769","article-title":"Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat","volume":"289","author":"Mankodi","year":"2000","journal-title":"Science"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/570","article-title":"Genetic mapping of a second myotonic dystrophy locus","volume":"19","author":"Ranum","year":"1998","journal-title":"Nat. Genet."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1126\/science.1062125","article-title":"Myotonic dystrophy type 2 caused by a CCTG expansion in intron I of ZNF9","volume":"293","author":"Liquori","year":"2001","journal-title":"Science"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1093\/nar\/24.22.4407","article-title":"Identification of a (CUG)(n) triplet repeat RNA-binding protein and its expression in myotonic dystrophy","volume":"24","author":"Timchenko","year":"1996","journal-title":"Nucleic Acids Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1126\/science.280.5364.737","article-title":"Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy","volume":"280","author":"Philips","year":"1998","journal-title":"Science"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1093\/emboj\/19.17.4439","article-title":"Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy","volume":"19","author":"Miller","year":"2000","journal-title":"EMBO J."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"11748","DOI":"10.1073\/pnas.0604970103","article-title":"Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy","volume":"103","author":"Kanadia","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1093\/hmg\/ddq277","article-title":"CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1","volume":"19","author":"Ward","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/hmg\/ddp570","article-title":"Heart-specific overexpression of CUGBP1 reproduces functional and molecular abnormalities of myotonic dystrophy type 1","volume":"19","author":"Koshelev","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1097-2765(02)00563-4","article-title":"Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy","volume":"10","author":"Mankodi","year":"2002","journal-title":"Mol. Cell"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nm.2374","article-title":"Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy","volume":"17","author":"Fugier","year":"2011","journal-title":"Nat. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1093\/hmg\/ddi223","article-title":"Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic\/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1","volume":"14","author":"Kimura","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Mart\u00ednez, A., Soblechero-Mart\u00edn, P., De-la-Puente-Ovejero, L., Nogales-Gadea, G., and Arechavala-Gomeza, V. (2020). An Overview of Alternative Splicing Defects Implicated in Myotonic Dystrophy Type I. Genes (Basel), 11.","DOI":"10.3390\/genes11091109"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/ng0796-325","article-title":"Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy","volume":"13","author":"Reddy","year":"1996","journal-title":"Nat. Genet."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/hmg\/ddh161","article-title":"Six5 is required for spermatogenic cell survival and spermiogenesis","volume":"13","author":"Sarkar","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1023\/A:1020881520353","article-title":"Characterization of cardiac conduction system abnormalities in mice with targeted disruption of Six5 gene","volume":"7","author":"Wakimoto","year":"2002","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1093\/hmg\/ddh266","article-title":"Transgenic overexpression of human DMPK accumulates into hypertrophic cardiomyopathy, myotonic myophaty and hypotension traits of myotonic dystrophy","volume":"13","author":"Reyes","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.nmd.2006.12.015","article-title":"Ribonuclear foci at the neuromuscular junction in myotonic dystrophy type 1","volume":"17","author":"Wheeler","year":"2007","journal-title":"Neuromuscul. Disord."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/ng0297-190","article-title":"Moderate intergenerational and somatic instability of a 55-CTG repeat in transgenic mice","volume":"15","author":"Gourdon","year":"1997","journal-title":"Nat. Genet."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/hmg\/9.8.1185","article-title":"Transgenic mice carrying large human genomic sequences with expanded CTG repeat mimic closely the DM CTG repeat intergenerational and somatic instability","volume":"9","author":"Seznec","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"ref_110","first-page":"0488","article-title":"CTG trinucleotide repeat \u201cbig jumps\u201d: Large expansions, small mice","volume":"3","author":"Foiry","year":"2007","journal-title":"PLoS Genet."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/ng1857","article-title":"Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy","volume":"38","author":"Mahadevan","year":"2006","journal-title":"Nat. Genet."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1172\/JCI32308","article-title":"Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy","volume":"117","author":"Wang","year":"2007","journal-title":"J. Clin. Invest."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1073\/pnas.0708519105","article-title":"Expanded CTG repeats within the DMPK 3\u2032 UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy","volume":"105","author":"Orengo","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/ng.2007.28","article-title":"RNA toxicity in myotonic muscular dystrophy induces NKX2-5 expression","volume":"40","author":"Yadava","year":"2008","journal-title":"Nat. Genet."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1126\/science.1088583","article-title":"A Muscleblind Knockout Model for Myotonic Dystrophy","volume":"302","author":"Kanadia","year":"2003","journal-title":"Science"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1085\/jgp.200609635","article-title":"Muscle chloride channel dysfunction in two mouse models of myotonic dystrophy","volume":"129","author":"Lueck","year":"2007","journal-title":"J. Gen. Physiol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0009857","article-title":"Muscleblind1, but not Dmpk or Six5, contributes to a complex phenotype of muscular and motivational deficits in mouse models of Myotonic Dystrophy","volume":"5","author":"Matynia","year":"2010","journal-title":"PLoS ONE"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/dvdy.21428","article-title":"Muscleblind-like 2 (Mbnl2) -deficient mice as a model for myotonic dystrophy","volume":"237","author":"Hao","year":"2008","journal-title":"Dev. Dyn."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41422-020-0276-y","article-title":"New myotonic dystrophy type 1 mouse model","volume":"30","author":"Lei","year":"2020","journal-title":"Cell Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00424-020-02368-3","article-title":"Skeletal muscle Ca V 1. 1 channelopathies","volume":"472","author":"Flucher","year":"2020","journal-title":"Eur. J. Physiol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1086\/378566","article-title":"Confirmation of the Type 2 Myotonic Dystrophy (CCTG)n Expansion Mutation in Patients with Proximal Myotonic Myopathy\/Proximal Myotonic Dystrophy of Different European Origins: A Single Shared Haplotype Indicates an Ancestral Founder Effect","volume":"73","author":"Bachinski","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Prokic, I., Cowling, B.S., Kutchukian, C., Kretz, C., Tasfaout, H., Gache, V., Hergueux, J., Wendling, O., Ferry, A., and Toussaint, A. (2020). Differential physiological role of BIN1 isoforms in skeletal muscle development, function and regeneration. Dis. Model. Mech., 1\u201354.","DOI":"10.1242\/dmm.044354"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1212\/WNL.0000000000000797","article-title":"Population-based incidence and prevalence of facioscapulohumeral dystrophy","volume":"83","author":"Deenen","year":"2014","journal-title":"Neurology"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0378-1119(99)00267-X","article-title":"Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element","volume":"236","author":"Beckers","year":"1999","journal-title":"Gene"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.molmed.2015.02.011","article-title":"Emerging preclinical animal models for FSHD","volume":"21","author":"Lek","year":"2015","journal-title":"Trends Mol. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/ana.22275","article-title":"DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo","volume":"69","author":"Wallace","year":"2011","journal-title":"Ann. Neurol."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Krom, Y.D., Thijssen, P.E., Young, J.M., den Hamer, B., Balog, J., Yao, Z., Maves, L., Snider, L., Knopp, P., and Zammit, P.S. (2013). Intrinsic Epigenetic Regulation of the D4Z4 Macrosatellite Repeat in a Transgenic Mouse Model for FSHD. PLoS Genet., 9.","DOI":"10.1371\/journal.pgen.1003415"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.celrep.2014.07.056","article-title":"Dominant Lethal Pathologies in Male Mice Engineered to Contain an X-Linked DUX4 Transgene","volume":"8","author":"Dandapat","year":"2014","journal-title":"Cell Rep."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-00730-1","article-title":"Muscle pathology from stochastic low level DUX4 expression in an FSHD mouse model","volume":"8","author":"Bosnakovski","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1093\/hmg\/ddu028","article-title":"Human skeletal muscle xenograft as a new preclinical model for muscle disorders","volume":"23","author":"Zhang","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/mt.2016.111","article-title":"Morpholino-mediated Knockdown of DUX4 Toward Facioscapulohumeral Muscular Dystrophy Therapeutics","volume":"24","author":"Chen","year":"2016","journal-title":"Mol. Ther."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Mueller, A.L., O\u2019Neill, A., Jones, T.I., Llach, A., Rojas, L.A., Sakellariou, P., Stadler, G., Wright, W.E., Eyerman, D., and Jones, P.L. (2019). Muscle xenografts reproduce key molecular features of facioscapulohumeral muscular dystrophy. Exp. Neurol., 320.","DOI":"10.1016\/j.expneurol.2019.113011"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature04422","article-title":"Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1","volume":"439","author":"Gabellini","year":"2006","journal-title":"Nature"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Caruso, N., Herberth, B., Bartoli, M., Puppo, F., Dumonceaux, J., Zimmermann, A., Denadai, S., Leboss\u00e9, M., Roche, S., and Geng, L. (2013). Deregulation of the Protocadherin Gene FAT1 Alters Muscle Shapes: Implications for the Pathogenesis of Facioscapulohumeral Dystrophy. PLoS Genet., 9.","DOI":"10.1371\/journal.pgen.1003550"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.molmed.2011.01.001","article-title":"Facioscapulohumeral muscular dystrophy and DUX4: Breaking the silence","volume":"17","author":"Tawil","year":"2011","journal-title":"Trends Mol. Med."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2044-5040-4-12","article-title":"Facioscapulohumeral dystrophy: The path to consensus on pathophysiology","volume":"4","author":"Tawil","year":"2014","journal-title":"Skelet. Muscle"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00439-011-1100-z","article-title":"Facioscapulohumeral muscular dystrophy (FSHD): An enigma unravelled?","volume":"131","author":"Richards","year":"2012","journal-title":"Hum. Genet."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.123538","article-title":"AAV-mediated follistatin gene therapy improves functional outcomes in the TIC-DUX4 mouse model of FSHD","volume":"3","author":"Giesige","year":"2018","journal-title":"JCI insight"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0192657","article-title":"A cre-inducible DUX4 transgenic mouse model for investigating facioscapulohumeral muscular dystrophy","volume":"13","author":"Jones","year":"2018","journal-title":"PLoS ONE"},{"key":"ref_140","first-page":"666","article-title":"Multicore disease. A recently recognized congenital myopathy associated with multifocal degeneration of muscle fibers","volume":"46","author":"Engel","year":"1971","journal-title":"Mayo Clin. Proc."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-2-25","article-title":"Central core disease","volume":"2","author":"Jungbluth","year":"2007","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1212\/01.wnl.0000188870.37076.f2","article-title":"Minicore myopathy with ophthalmoplegia caused by mutations in the ryanodine receptor type 1 gene","volume":"65","author":"Jungbluth","year":"2005","journal-title":"Neurology"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/1531-8249(200011)48:5<745::AID-ANA8>3.0.CO;2-F","article-title":"Multi-Minicore Disease \u2013 Searching for Boundaries: Phenotype Analysis of 38 Cases","volume":"48","author":"Ferreiro","year":"2000","journal-title":"Am. Neurol. Assoc."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/brain\/79.4.610","article-title":"A new congenital non-progressive myopathy","volume":"79","author":"Shy","year":"1956","journal-title":"Brain"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s13311-018-00677-1","article-title":"Ryanodine Receptor 1-Related Myopathies: Diagnostic and Therapeutic Approaches","volume":"15","author":"Lawal","year":"2018","journal-title":"Neurotherapeutics"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1086\/342719","article-title":"Mutations of the selenoprotein N gene, which is implicated in rigid spine muscular dystrophy, cause the classical phenotype of multiminicore disease: Reassessing the nosology of early-onset myopathies","volume":"71","author":"Ferreiro","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jocn.2018.12.024","article-title":"Congenital myopathy with a novel SELN missense mutation and the challenge to differentiate it from congenital muscular dystrophy","volume":"62","author":"Kazamel","year":"2019","journal-title":"J. Clin. Neurosci."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.nmd.2012.06.007","article-title":"Mutations in MYH7 cause Multi-minicore Disease (MmD) with variable cardiac involvement","volume":"22","author":"Cullup","year":"2012","journal-title":"Neuromuscul. Disord."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10048-012-0315-z","article-title":"Mutations in the satellite cell gene MEGF10 cause a recessive congenital myopathy with minicores","volume":"13","author":"Boyden","year":"2012","journal-title":"Neurogenetics"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.nmd.2009.12.005","article-title":"Multi-minicore disease and atypical periodic paralysis associated with novel mutations in the skeletal muscle ryanodine receptor (RYR1) gene","volume":"20","author":"Zhou","year":"2010","journal-title":"Neuromuscul. Disord."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.nmd.2019.03.007","article-title":"Recessive mutations in proximal I-band of TTN gene cause severe congenital multi-minicore disease without cardiac involvement","volume":"29","author":"Ge","year":"2019","journal-title":"Neuromuscul. Disord."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ajhg.2012.06.012","article-title":"Dominant mutation of CCDC78 in a unique congenital myopathy with prominent internal nuclei and atypical cores","volume":"91","author":"Majczenko","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/jmg.2004.020271","article-title":"Missense mutations of ACTA1 cause dominant congenital myopathy with cores","volume":"41","author":"Kaindl","year":"2004","journal-title":"J. Med. Genet."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00401-019-01963-8","article-title":"ACTN2 mutations cause \u201cMultiple structured Core Disease\u201d (MsCD)","volume":"137","author":"Lornage","year":"2020","journal-title":"Acta Neuropathol"},{"key":"ref_155","first-page":"1","article-title":"Recessive mutations in muscle-specific isoforms of FXR1 cause congenital multi-minicore myopathy","volume":"10","author":"Zaki","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/369556a0","article-title":"Excitation-contraction uncoupling and muscular degeneration in mice lacking functional skeletal muscle ryanodine-receptor gene","volume":"369","author":"Takeshima","year":"1994","journal-title":"Nature"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1073\/pnas.92.8.3381","article-title":"Abnormal junctions between surface membrane and sarcoplasmic reticulum in skeletal muscle with a mutation targeted to the ryanodine receptor","volume":"92","author":"Takekura","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"10331","DOI":"10.1074\/jbc.RA120.013846","article-title":"Bi-allelic expression of the RyR1 p.A4329D mutation decreases muscle strength in slow-twitch muscles in mice","volume":"295","author":"Elbaz","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1093\/hmg\/ddu602","article-title":"SEPN1, an endoplasmic reticulum-localized selenoprotein linked to skeletal muscle pathology, counteracts hyperoxidation by means of redox-regulating SERCA2 pump activity","volume":"24","author":"Marino","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"21813","DOI":"10.1073\/pnas.0912126106","article-title":"Ca2+ dysregulation in Ryr1I4895T\/wt mice causes congenital myopathy with progressive formation of minicores, cores, and nemaline rods","volume":"106","author":"Zvaritch","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Fusto, A., Moyle, L.A., Gilbert, P.M., and Pegoraro, E. (2019). Cored in the act: The use of models to understand core myopathies. DMM Dis. Model. Mech., 12.","DOI":"10.1242\/dmm.041368"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/hmg\/ddz092","article-title":"Quantitative RyR1 reduction and loss of calcium sensitivity of RyR1Q1970fsX16+A4329D cause cores and loss of muscle strength","volume":"28","author":"Elbaz","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/hmg\/ddq515","article-title":"Satellite cell loss and impaired muscle regeneration in selenoprotein N deficiency","volume":"20","author":"Castets","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/hmg\/ddt494","article-title":"Recessive TTN truncating mutations define novel forms of core myopathy with heart disease","volume":"23","author":"Chauveau","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.nmd.2013.01.004","article-title":"Congenital myopathies--clinical features and frequency of individual subtypes diagnosed over a 5-year period in the United Kingdom","volume":"23","author":"Maggi","year":"2013","journal-title":"Neuromuscul. Disord."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/ana.22510","article-title":"Prevalence of congenital myopathies in a representative pediatric united states population","volume":"70","author":"Amburgey","year":"2011","journal-title":"Ann. Neurol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/humu.20356","article-title":"Mutations in RYR1 in Malignant Hyperthermia and Central Core Disease","volume":"27","author":"Robinson","year":"2006","journal-title":"Hum. Mutat."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.nmd.2005.06.008","article-title":"Ryanodine receptor 1 mutations, dysregulation of calcium homeostasis and neuromuscular disorders","volume":"15","author":"Treves","year":"2005","journal-title":"Neuromuscul. Disord."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1096\/fj.05-4497fje","article-title":"Heat- and anesthesia-induced malignant hyperthermia in an RyR1 knock-in mouse","volume":"20","author":"Chelu","year":"2006","journal-title":"FASEB J."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cell.2008.02.042","article-title":"RyR1 S-Nitrosylation Underlies Environmental Heat Stroke and Sudden Death in Y522S RyR1 Knockin Mice","volume":"133","author":"Durham","year":"2008","journal-title":"Cell"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"21996","DOI":"10.1073\/pnas.0911496106","article-title":"Characterization and temporal development of cores in a mouse model of malignant hyperthermia","volume":"106","author":"Boncompagni","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1096\/fj.11-197582","article-title":"Mice expressing T4826I-RYR1 are viable but exhibit sex- and genotype-dependent susceptibility to malignant hyperthermia and muscle damage","volume":"26","author":"Yuen","year":"2012","journal-title":"FASEB J."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"18537","DOI":"10.1073\/pnas.0709312104","article-title":"An Ryr1I4895T mutation abolishes Ca2+ release channel function and delays development in homozygous offspring of a mutant mouse line","volume":"104","author":"Zvaritch","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"15060","DOI":"10.1073\/pnas.212498399","article-title":"The lipid phosphatase myotubularin is essential for skeletal muscle maintenance but not for myogenesis in mice","volume":"99","author":"Laugel","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/hmg\/ddr512","article-title":"Modeling the human MTM1 p.R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotype","volume":"21","author":"Pierson","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1172\/JCI71206","article-title":"Reducing dynamin 2 expression rescues X-linked centronuclear myopathy","volume":"124","author":"Cowling","year":"2014","journal-title":"J. Clin. Invest."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"8656","DOI":"10.1074\/jbc.RA119.010839","article-title":"The intragenic microRNA miR199A1 in the dynamin 2 gene contributes to the pathology of X-linked centronuclear myopathy","volume":"295","author":"Chen","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1093\/hmg\/ddq413","article-title":"A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice","volume":"19","author":"Durieux","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1172\/JCI46267","article-title":"Mice lacking microRNA 133a develop dynamin 2-dependent centronuclear myopathy","volume":"121","author":"Liu","year":"2011","journal-title":"J. Clin. Invest."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1172\/JCI90542","article-title":"Amphiphysin (BIN1) negatively regulates dynamin 2 for normal muscle maturation","volume":"127","author":"Cowling","year":"2017","journal-title":"J. Clin. Invest."},{"key":"ref_181","first-page":"1","article-title":"Physiological impact and disease reversion for the severe form of centronuclear myopathy linked to dynamin","volume":"5","author":"Kretz","year":"2020","journal-title":"JCI insight"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.nmd.2018.06.012","article-title":"An integrated modelling methodology for estimating the prevalence of centronuclear myopathy","volume":"28","author":"Vandersmissen","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/jmg.32.9.673","article-title":"The myotubular myopathies: Differential diagnosis of the X linked recessive, autosomal dominant, and autosomal recessive forms and present state of DNA studies","volume":"32","author":"Clarke","year":"1995","journal-title":"J. Med. Genet."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/01.jnen.0000171653.17213.2e","article-title":"X-linked myotubular and centronuclear myopathies","volume":"64","author":"Pierson","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-3-26","article-title":"Centronuclear (myotubular) myopathy","volume":"3","author":"Jungbluth","year":"2008","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"8910","DOI":"10.1073\/pnas.160255697","article-title":"Myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate","volume":"97","author":"Taylor","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pgen.1000372","article-title":"Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy","volume":"5","author":"Dowling","year":"2009","journal-title":"PLoS Genet."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.molmed.2012.04.004","article-title":"Myotubularin phosphoinositide phosphatases: Cellular functions and disease pathophysiology","volume":"18","author":"Hnia","year":"2012","journal-title":"Trends Mol. Med."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/978-94-007-5025-8_10","article-title":"Myotubularin Phosphoinositide Phosphatases in Human Diseases","volume":"Volume 362","author":"Amoasii","year":"2012","journal-title":"Phosphoinositides and Disease"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/jmg.27.5.284","article-title":"X linked neonatal centronuclear\/myotubular myopathy: Evidence for linkage to Xq28 DNA marker loci","volume":"27","author":"Thomas","year":"1990","journal-title":"J. Med. Genet."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/oxfordjournals.hmg.a018913","article-title":"Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway","volume":"9","author":"Blondeau","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"Tronch\u00e8re, H., Laporte, J., Pendaries, C., Chaussade, C., Liaubet, L., Pirola, L., Mandel, J.L., and Payrastre, B. (2003). Production of PtdIns(5)P by the phosphoinositide 3-phosphatase myotubularin in mammalian cells H\u00e9l\u00e8ne. J Biol Chem, 1\u201336.","DOI":"10.1074\/jbc.M311071200"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1091\/mbc.e08-04-0367","article-title":"Sequential Actions of Myotubularin Lipid Phosphatases Regulate Endosomal PI(3)P and Growth Factor Receptor Traffickin","volume":"19","author":"Cao","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ng0696-175","article-title":"A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast","volume":"13","author":"Laporte","year":"1996","journal-title":"Nat. Genet."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/(SICI)1098-1004(200005)15:5<393::AID-HUMU1>3.0.CO;2-R","article-title":"MTM1 mutations in X-linked myotubular myopathy","volume":"15","author":"Laporte","year":"2000","journal-title":"Hum. Mutat."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00439-002-0869-1","article-title":"Characterisation of mutations in 77 patients with X-linked myotubular myopathy, including a family with a very mild phenotype","volume":"112","author":"Biancalana","year":"2003","journal-title":"Hum. Genet."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0960-8966(02)00153-0","article-title":"Genotype-phenotype correlations in X-linked myotubular myopathy","volume":"12","author":"McEntagart","year":"2002","journal-title":"Neuromuscul. Disord."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1212\/WNL.0000000000004415","article-title":"A natural history study of X-linked myotubular myopathy","volume":"89","author":"Amburgey","year":"2017","journal-title":"Neurology"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/mus.26018","article-title":"A multicenter, retrospective medical record review of X-linked myotubular myopathy: The recensus study","volume":"57","author":"Beggs","year":"2018","journal-title":"Muscle and Nerve"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0022-3476(99)70417-8","article-title":"Medical complications in long-term survivors with X-linked myotubular myopathy","volume":"134","author":"Herman","year":"1999","journal-title":"J. Pediatr."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"18763","DOI":"10.1073\/pnas.0900705106","article-title":"T-tubule disorganization and defective excitation-contraction coupling in muscle fibers lacking myotubularin lipid phosphatase","volume":"106","author":"Messaddeq","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"14432","DOI":"10.1073\/pnas.1604099113","article-title":"Phosphatidylinositol 3-Kinase Inhibition restores Ca2+ release defects and prolongs survival in myotubularin-deficient mice","volume":"113","author":"Kutchukian","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ceca.2019.04.004","article-title":"Ca2+-induced sarcoplasmic reticulum Ca2+ release in myotubularin-deficient muscle fibers","volume":"80","author":"Kutchukian","year":"2019","journal-title":"Cell Calcium"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1093\/hmg\/ddn112","article-title":"AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis","volume":"17","author":"Fougerousse","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/hmg\/ddt003","article-title":"Enzyme replacement therapy rescues weakness and improves muscle pathology in mice with X-linked myotubular myopathy","volume":"22","author":"Lawlor","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"ref_206","first-page":"852","article-title":"Myotubular myopathy and the neuromuscular junction: A novel therapeutic approach from mouse models","volume":"5","author":"Dowling","year":"2012","journal-title":"DMM Dis. Model. Mech."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1172\/JCI86841","article-title":"PIK3C2B inhibition improves function and prolongs survival in myotubular myopathy animal models","volume":"126","author":"Sabha","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms15661","article-title":"Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice","volume":"8","author":"Tasfaout","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_209","doi-asserted-by":"crossref","unstructured":"Gayi, E., Neff, L.A., Massana Mu\u00f1oz, X., Ismail, H.M., Sierra, M., Mercier, T., D\u00e9costerd, L.A., Laporte, J., Cowling, B.S., and Dorchies, O.M. (2018). Tamoxifen prolongs survival and alleviates symptoms in mice with fatal X-linked myotubular myopathy. Nat. Commun., 9.","DOI":"10.1038\/s41467-018-07058-4"},{"key":"ref_210","doi-asserted-by":"crossref","unstructured":"Maani, N., Sabha, N., Rezai, K., Ramani, A., Groom, L., Eltayeb, N., Mavandadnejad, F., Pang, A., Russo, G., and Brudno, M. (2018). Tamoxifen therapy in a murine model of myotubular myopathy. Nat. Commun., 9.","DOI":"10.1038\/s41467-018-07057-5"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/ng1657","article-title":"Mutations in dynamin 2 cause dominant centronuclear myopathy","volume":"37","author":"Bitoun","year":"2005","journal-title":"Nat. Genet."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/ng0305-215","article-title":"Dynamin in disease","volume":"37","author":"McNiven","year":"2005","journal-title":"Nat. Genet."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/ana.21235","article-title":"Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset","volume":"62","author":"Bitoun","year":"2007","journal-title":"Ann. Neurol."},{"key":"ref_214","first-page":"949","article-title":"Mutation Spectrum in the Large GTPase Dynamin 2, and Genotype\u2013Phenotype Correlation in Autosomal Dominant Centronuclear Myopathy","volume":"33","author":"Biancalana","year":"2013","journal-title":"Hum Mutat"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1600-0854.2012.01348.x","article-title":"A Centronuclear Myopathy - Dynamin 2 Mutation Impairs Autophagy in Mice","volume":"13","author":"Durieux","year":"2012","journal-title":"Traffic"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1242\/bio.020263","article-title":"Calcium homeostasis alterations in a mouse model of the dynamin 2-related centronuclear myopathy","volume":"5","author":"Fraysse","year":"2016","journal-title":"Biol. Open"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"7369","DOI":"10.1113\/JP274990","article-title":"Impaired excitation\u2013contraction coupling in muscle fibres from the dynamin2R465W mouse model of centronuclear myopathy","volume":"595","author":"Kutchukian","year":"2017","journal-title":"J. Physiol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"239","DOI":"10.15252\/emmm.201707988","article-title":"Allele-specific silencing therapy for Dynamin 2-related dominant centronuclear myopathy","volume":"10","author":"Trochet","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"11066","DOI":"10.1073\/pnas.1808170115","article-title":"Reducing dynamin 2 (DNM2) rescues DNM2-related dominant centronuclear myopathy","volume":"115","author":"Buono","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.omtn.2019.02.019","article-title":"Allele-Specific CRISPR\/Cas9 Correction of a Heterozygous DNM2 Mutation Rescues Centronuclear Myopathy Cell Phenotypes","volume":"16","author":"Rabai","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.256.5058.789","article-title":"Malignant hyperthermia","volume":"256","author":"MacLennan","year":"1992","journal-title":"Science"},{"key":"ref_222","doi-asserted-by":"crossref","unstructured":"Britt, B.A. (1987). Malignant Hyperthermia, Martinus Nijhoff Publishing.","DOI":"10.1007\/978-1-4613-2079-1"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-2-21","article-title":"Malignant hyperthermia","volume":"2","author":"Rosenberg","year":"2007","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/00000542-198204000-00005","article-title":"Dantrolene in human malignant hyperthermia Anesthesiology","volume":"56","author":"Kolb","year":"1982","journal-title":"Anesthesiology"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1126\/science.1862346","article-title":"Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia","volume":"253","author":"Fujii","year":"1991","journal-title":"Science"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/343559a0","article-title":"Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia","volume":"343","author":"MacLennan","year":"1990","journal-title":"Nature"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/ALN.0000000000001878","article-title":"Malignant Hyperthermia in the Post-Genomics Era: New Perspectives on an Old Concept","volume":"128","author":"Riazi","year":"2018","journal-title":"Anesthesiology"},{"key":"ref_228","doi-asserted-by":"crossref","unstructured":"Goebel, H.H., Sewry, C.A., and Weller, R.O. (2013). Introduction to Muscle Disease: Pathology and Genetics, Wiley.","DOI":"10.1002\/9781118635469"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/ncomms2501","article-title":"Disease mutations in the ryanodine receptor N-terminal region couple to a mobile intersubunit interface","volume":"4","author":"Kimlicka","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1124\/mol.110.067959","article-title":"Functional and biochemical properties of ryanodine receptor type 1 channels from heterozygous R163C malignant hyperthermia-susceptible mice","volume":"79","author":"Feng","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1074\/jbc.272.8.5256","article-title":"Functional characterization of a distinct ryanodine receptor mutation in human malignant hyperthermia-susceptible muscle","volume":"272","author":"Richter","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/BF00141551","article-title":"Ca2+ inactivation, Mg2+ inhibition and malignant hyperthermia","volume":"14","author":"Lamb","year":"1993","journal-title":"J. Muscle Res. Cell Motil."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.1073\/pnas.1619835114","article-title":"Dantrolene requires Mg2+ to arrest malignant hyperthermia","volume":"114","author":"Choi","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1124\/mol.119.116475","article-title":"Dantrolene requires MG2+ and ATP to inhibit the ryanodine receptor","volume":"96","author":"Magyar","year":"2019","journal-title":"Mol. Pharmacol."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/252728a0","article-title":"Effect of dantrolene sodium on calcium movements in single muscle fibres","volume":"252","author":"Hainaut","year":"1974","journal-title":"Nature"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/bja\/48.4.297","article-title":"Porcine malignant hyperthermia. I: Metabolic and physiological changes","volume":"48","author":"Lucre","year":"1976","journal-title":"Br. J. Anaesth."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/bja\/48.4.305","article-title":"Porcine malignant hyperthermia. II: Heat production","volume":"48","author":"Hall","year":"1976","journal-title":"Br. J. Anaesth."},{"key":"ref_238","first-page":"197","article-title":"Porcine malignant hyperthermia","volume":"84","author":"Nelson","year":"1976","journal-title":"Am. J. Pathol."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/bja\/47.1.62","article-title":"Control of the malignant hyperpyrexic syndrome in mhs swine by dantrolene sodium","volume":"47","author":"Harrison","year":"1975","journal-title":"Br. J. Anaesth."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00000542-197601000-00013","article-title":"Porcine malignant hyperthermia: Effect of dantrolene sodium on in-vitro halothane-induced contraction of susceptible muscle","volume":"44","author":"Anderson","year":"1976","journal-title":"Anesthesiology"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/00000542-197606000-00005","article-title":"Dantrolene in porcine malignant hyperthermia","volume":"44","author":"Gronert","year":"1976","journal-title":"Anesthesiology"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nm.2598","article-title":"AICAR Prevents Heat Induced Sudden Death in RyR1 Mutant Mice Independent of AMPK Activation","volume":"18","author":"Lanner","year":"2012","journal-title":"Nat. Med."},{"key":"ref_243","doi-asserted-by":"crossref","unstructured":"Wang, H.J., Lee, C.S., Yee, R.S.Z., Groom, L., Friedman, I., Babcock, L., Georgiou, D.K., Hong, J., Hanna, A.D., and Recio, J. (2020). Adaptive thermogenesis enhances the life-threatening response to heat in mice with an Ryr1 mutation. Nat. Commun., 11.","DOI":"10.1038\/s41467-020-18865-z"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1097\/00000542-200612000-00016","article-title":"Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse","volume":"105","author":"Yang","year":"2006","journal-title":"Anesthesiology"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.bja.2018.07.008","article-title":"Malignant hyperthermia, environmental heat stress, and intracellular calcium dysregulation in a mouse model expressing the p.G2435R variant of RYR1","volume":"121","author":"Lopez","year":"2018","journal-title":"Br. J. Anaesth."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/toxsci\/kfy256","article-title":"Comparison of Chlorantraniliprole and Flubendiamide Activity Toward Wild-Type and Malignant Hyperthermia-Susceptible Ryanodine Receptors and Heat Stress Intolerance","volume":"167","author":"Truong","year":"2019","journal-title":"Toxicol. Sci."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/toxsci\/kfz062","article-title":"Additional Safety Assessments Needed for Diamide Insecticides","volume":"171","author":"Pessah","year":"2019","journal-title":"Toxicol. Sci."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/23\/8935\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:37:06Z","timestamp":1760179026000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/23\/8935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,25]]},"references-count":247,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["ijms21238935"],"URL":"https:\/\/doi.org\/10.3390\/ijms21238935","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,25]]}}}